Description of the Interdigitation Retinal Area by SD-OCT: An Exploratory Study
NCT ID: NCT03326908
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2017-10-12
2018-01-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for 3D Measurements of the Eye
NCT01663688
A Pilot Study for the Evaluation of the Safety and Performance of a Combined OCT System
NCT03419390
Anterior Segment Spectral-domain Optical Coherence Tomography in Patients With Closed Globe Injury
NCT02638025
SD-OCT Angiography
NCT02510885
Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis
NCT01958567
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal conditions of light exposure
Spectral Domain Optical Coherence Tomography (SD-OCT):
Five SD-OCTs will be produced under the same lighting conditions (photopic).
* At baseline
* 20 minutes after baseline
* 25 minutes after baseline
* 45 minutes after baseline
* 60 minutes after baseline
Spectral Domain Optical Coherence Tomography
Five SD-OCTs will be performed with various conditions of enlightenment.
Light variations
Spectral Domain Optical Coherence Tomography (SD-OCT):
Five SD-OCT will be performed:
* at baseline, in a room with photopic artificial lighting (400 lux)
* after a period of adaptation to the dark (20 minutes in the dark: 0 lux)
* after 5 min of retinal glare, obtained by means of a projection of light of 1000 lux on the fundus of eye
* 15 minutes after this period of retinal glare, in photopic artificial lighting
* 30 minutes after the period of retinal glare, in photopic artificial lighting
Spectral Domain Optical Coherence Tomography
Five SD-OCTs will be performed with various conditions of enlightenment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spectral Domain Optical Coherence Tomography
Five SD-OCTs will be performed with various conditions of enlightenment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consent to participate
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Ophtalmologique Adolphe de Rothschild
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation Ophtalmologique A. de Rothschild
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mathis T, Vasseur V, Zuber K, Arej N, Loria O, Kodjikian L, Sennlaub F, Mauget-Faysse M. Light-induced modifications of the outer retinal hyperreflective layers on spectral-domain optical coherence tomography in humans: an experimental study. Acta Ophthalmol. 2021 Nov;99(7):765-772. doi: 10.1111/aos.14723. Epub 2021 Jan 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMT_2017_16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.